Lymphoid enhancer-binding factor 1

From Wikipedia, the free encyclopedia


Lymphoid enhancer-binding factor 1
PDB rendering based on 2lef.
Available structures: 2lef
Identifiers
Symbol(s) LEF1; DKFZp586H0919; TCF1ALPHA
External IDs OMIM: 153245 MGI96770 HomoloGene7813
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 51176 16842
Ensembl ENSG00000138795 ENSMUSG00000027985
Uniprot Q9UJU2 Q3TYB0
Refseq NM_016269 (mRNA)
NP_057353 (protein)
NM_010703 (mRNA)
NP_034833 (protein)
Location Chr 4: 109.19 - 109.31 Mb Chr 3: 131.1 - 131.21 Mb
Pubmed search [1] [2]

Lymphoid enhancer-binding factor 1, also known as LEF1, is a human gene.

Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-B and T cells. It binds to a functionally important site in the T-cell receptor-alpha (TCRA; MIM 186880) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 (HMG1; MIM 163905).[supplied by OMIM][1]

[edit] References

[edit] Further reading

  • Waterman ML (2004). "Lymphoid enhancer factor/T cell factor expression in colorectal cancer.". Cancer Metastasis Rev. 23 (1-2): 41–52. PMID 15000148. 
  • Skokowa J, Welte K (2007). "LEF-1 is a decisive transcription factor in neutrophil granulopoiesis.". Ann. N. Y. Acad. Sci. 1106: 143–51. doi:10.1196/annals.1392.012. PMID 17360796. 
  • Milatovich A, Travis A, Grosschedl R, Francke U (1992). "Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf.". Genomics 11 (4): 1040–8. PMID 1783375. 
  • Travis A, Amsterdam A, Belanger C, Grosschedl R (1991). "LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]". Genes Dev. 5 (5): 880–94. PMID 1827423. 
  • van de Wetering M, Oosterwegel M, Dooijes D, Clevers H (1991). "Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.". EMBO J. 10 (1): 123–32. PMID 1989880. 
  • Waterman ML, Fischer WH, Jones KA (1991). "A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer.". Genes Dev. 5 (4): 656–69. PMID 2010090. 
  • Zhou P, Byrne C, Jacobs J, Fuchs E (1995). "Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate.". Genes Dev. 9 (6): 700–13. PMID 7537238. 
  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298. 
  • Prieve MG, Guttridge KL, Munguia JE, Waterman ML (1996). "The nuclear localization signal of lymphoid enhancer factor-1 is recognized by two differentially expressed Srp1-nuclear localization sequence receptor proteins.". J. Biol. Chem. 271 (13): 7654–8. PMID 8631802. 
  • Behrens J, von Kries JP, Kühl M, et al. (1996). "Functional interaction of beta-catenin with the transcription factor LEF-1.". Nature 382 (6592): 638–42. doi:10.1038/382638a0. PMID 8757136. 
  • Bagga R, Emerson BM (1997). "An HMG I/Y-containing repressor complex and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro.". Genes Dev. 11 (5): 629–39. PMID 9119227. 
  • Bruhn L, Munnerlyn A, Grosschedl R (1997). "ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.". Genes Dev. 11 (5): 640–53. PMID 9119228. 
  • Brannon M, Gomperts M, Sumoy L, et al. (1997). "A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus.". Genes Dev. 11 (18): 2359–70. PMID 9308964. 
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149. 
  • Korinek V, Barker N, Willert K, et al. (1998). "Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse.". Mol. Cell. Biol. 18 (3): 1248–56. PMID 9488439. 
  • Prieve MG, Guttridge KL, Munguia J, Waterman ML (1998). "Differential importin-alpha recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1.". Mol. Cell. Biol. 18 (8): 4819–32. PMID 9671491. 
  • Levanon D, Goldstein RE, Bernstein Y, et al. (1998). "Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.". Proc. Natl. Acad. Sci. U.S.A. 95 (20): 11590–5. PMID 9751710. 
  • Hovanes K, Li TW, Waterman ML (2000). "The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing.". Nucleic Acids Res. 28 (9): 1994–2003. PMID 10756202. 
  • Labbé E, Letamendia A, Attisano L (2000). "Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.". Proc. Natl. Acad. Sci. U.S.A. 97 (15): 8358–63. doi:10.1073/pnas.150152697. PMID 10890911. 
  • Brantjes H, Roose J, van De Wetering M, Clevers H (2001). "All Tcf HMG box transcription factors interact with Groucho-related co-repressors.". Nucleic Acids Res. 29 (7): 1410–9. PMID 11266540. 

[edit] External links


This article incorporates text from the United States National Library of Medicine, which is in the public domain.